Keywords: decline, rhone-poulenc, expected, net, profits, down, million
DECLINE AT RHONE-POULENC AS EXPECTED
Article | 21 February 1994
Net profits were down 36.5% in 1993 to 962 million French francs ($164 million) at French chemical and pharmaceutical company Rhone-Poulenc. The company had ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- New study shows UCB's Neupro reduces NSBP in RLS patient
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
